Fibromyalgia in Indian patients with SLE.

Abstract:

:One hundred and fifty-eight patients with SLE were prospectively studied at a tertiary referral centre in India to ascertain the prevalence and clinical profile of fibromyalgia (FM) in Indian patients with lupus. An attempt was made to determine whether socio-demographic factors or disease characteristics differ in SLE patients with and without FM. Only 13 patients (8.2%) in our cohort were found to have fibromyalgia. Their clinical profiles were similar to that reported in other series. Corticosteroid withdrawal or dose reduction was the probable precipitating factor in nearly one-third of our patients. Age, sex, marital status, educational level, disease duration, disease activity and the organ involvement in patients with SLE and FM were comparable to those in patients not having FM. Fibromyalgia appears to be distinctly uncommon in Indian patients with lupus. A strong family support system, the virtual lack of disability benefits and/or racial variations in pain threshold could be the likely factors responsible for the low prevalence of the disease observed in Indian patients with SLE.

journal_name

Lupus

journal_title

Lupus

authors

Handa R,Aggarwal P,Wali JP,Wig N,Dwivedi SN

doi

10.1191/096120398678920497

subject

Has Abstract

pub_date

1998-01-01 00:00:00

pages

475-8

issue

7

eissn

0961-2033

issn

1477-0962

journal_volume

7

pub_type

杂志文章

相关文献

LUPUS文献大全
  • The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

    abstract::Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308100659

    authors: Rosenbaum E,Krebs E,Cohen M,Tiliakos A,Derk CT

    更新日期:2009-06-01 00:00:00

  • Wegener's granulomatosis: disease course, assessment of activity and extent and treatment.

    abstract::Wegener's granulomatosis (WG) belongs to the group of necrotizing primary systemic vasculitides of unknown etiology, that are associated with anti-neutrophil cytoplasmic antibodies. The pathological hallmark of WG is the coexistence of vasculitis and granuloma. Due to more sensitive diagnostic instruments, especially ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920118

    authors: de Groot K,Gross WL

    更新日期:1998-01-01 00:00:00

  • What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?

    abstract::Heart valve disease (HVD) is the most common cardiac manifestation in the antiphospholipid syndrome (APS). Valve lesions should be described according to the established definition. HVD is progressive despite anticoagulant/antiplatelet treatments. Around 4-6% of patients with HVD in APS will require valve replacement ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314534307

    authors: Amigo MC

    更新日期:2014-10-01 00:00:00

  • Superior mesenteric artery syndrome and intra-abdominal compartment syndrome in systemic lupus erythematosus.

    abstract::Gastrointestinal manifestations of systemic lupus erythematosus (SLE) are common, occurring in about 50% of cases. They are usually mild, in the form of mouth ulcers, nausea, heartburn and mild abdominal pain, but they can be severe in cases of gastrointestinal vasculitis. In this report we describe an unusual combina...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313517150

    authors: Bedaiwi M,Alkubeyyer MA,Al Arfaj AS

    更新日期:2014-02-01 00:00:00

  • C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.

    abstract:BACKGROUND:Complement activation plays a role in pathogenesis of the antiphospholipid syndrome (APS), but the involvement of the C5b-9 membrane attack complex (MAC) is unknown. Here we studied the effects of human polyclonal antiphospholipid (aPL) antibodies on thrombosis and tissue factor (TF) up-regulation in C6 defi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312458839

    authors: Carrera-Marín A,Romay-Penabad Z,Papalardo E,Reyes-Maldonado E,García-Latorre E,Vargas G,Shilagard T,Pierangeli S

    更新日期:2012-12-01 00:00:00

  • Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association.

    abstract::This report considers the rare situation in which primary antiphospholipid syndrome (PAPS) is linked with thrombotic thrombocytopenic purpura (TTP). It describes the case of a young lady with PAPS, characterized by recurring cerebro-vascular abnormalities and marked livedo reticularis, combined with circulating antica...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308101958

    authors: de Carvalho JF,Freitas CA,Lima IV,Leite CC,Lage LV

    更新日期:2009-08-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves.

    abstract:OBJECTIVE:To examine the potential immunologic mechanism and involvement of antiphospholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphospholipid syndrome (APS). METHODS:Immunoperoxidase and immunofluorescence staining methods were used to evaluate 13 heart valve specimens derive...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500306

    authors: Ziporen L,Goldberg I,Arad M,Hojnik M,Ordi-Ros J,Afek A,Blank M,Sandbank Y,Vilardell-Tarres M,de Torres I,Weinberger A,Asherson RA,Kopolovic Y,Shoenfeld Y

    更新日期:1996-06-01 00:00:00

  • The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.

    abstract::This study investigates specificity, sensitivity and concomitant presence of antibodies against histone H1 (H1), nucleosomes (NUC), chromatin (CHR) and dsDNA in patients with systemic lupus erythematosus (SLE), analyses their association with SLE disease activity and characterizes the immunodominant epitope reactivity...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu247oa

    authors: Schett G,Smole J,Zimmermann C,Hiesberger H,Hoefler E,Fournel S,Muller S,Rubin RL,Steiner G

    更新日期:2002-01-01 00:00:00

  • Accelerated atherosclerosis and coronary disease in SLE.

    abstract::Atherosclerosis may represent a significant cause of death and morbidity in patients with systemic lupus erythematosus. Coronary involvement is more premature in lupus patients. We present the case of a young woman diagnosed with SLE at the age of 20 years who had a myocardial infarction at age 29 years. We review the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600704

    authors: Farhey Y,Hess EV

    更新日期:1997-01-01 00:00:00

  • Skeletal muscle lymphocytic vasculitis in systemic lupus erythematosus: relation to disease activity.

    abstract::Lymphocytic vasculitis (LV) characterises systemic lupus erythematosus (SLE) and this potentially reversible lesion, which may be subclinical, may imply overt systemic disease activity. Needle quadriceps muscle biopsy was performed in 26 unselected patients with SLE and the presence of LV in these muscle specimens was...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400213

    authors: Lim KL,Lowe J,Powell RJ

    更新日期:1995-04-01 00:00:00

  • Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?

    abstract::The use of TNF alpha (TNFalpha) inhibitors has made a strong impact on the management of rheumatoid and psoriatic arthritis, ankylosing spondylitis and Crohn disease. Side effects of these agents include the development of autoantibodies and a lupus-like syndrome (drug-related lupus, DRL). Here, a case of a patient wh...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308093922

    authors: Kocharla L,Mongey AB

    更新日期:2009-02-01 00:00:00

  • Severe valvular heart disease in a patient with primary antiphospholipid syndrome.

    abstract::Valvular replacement was performed in a patient with primary antiphospholipid syndrome and severe mitral insufficiency. The valvular tissue presented thrombotic phenomena and fibrosis with minimum inflammatory component. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:

    authors: Alvarez-Blanco A,Egurbide-Arberas MV,Aguirre-Errasti C

    更新日期:1994-10-01 00:00:00

  • The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center.

    abstract::We retrospectively evaluated the clinical outcome of 45 female and 11 male patients with biopsy-proven lupus nephritis, followed at our hospital between February 1974 and February 1990. In the majority signs of nephritis were present at the time systemic lupus erythematosus was diagnosed (range: -42-156 months) and th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100207

    authors: Derksen RH,Hené RJ,Kater L

    更新日期:1992-02-01 00:00:00

  • Immunology of antiphospholipid antibodies and their interaction with plasma proteins.

    abstract::'Antiphospholipid' (aPL) antibodies are of clinical importance because of their strong association with vascular thrombosis, recurrent pregnancy loss, thrombocytopenia and other clinical manifestations like livedo reticularis, chorea and cardiac valvular disease. While aPL antibodies have traditionally been thought to...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500212

    authors: Kandiah DA,Krilis SA

    更新日期:1996-04-01 00:00:00

  • Prolactin levels in patients with systemic lupus erythematosus: a case controlled study.

    abstract::Recent accumulated evidence suggests that prolactin (PRL) is an important immunomodulator and might have a role in the pathogenesis of systemic lupus erythematosus (SLE). Our aim was to assess the frequency of hyperprolactinemia in women with SLE and to evaluate its correlation with disease activity. PRL plasma levels...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920361

    authors: Jimena P,Aguirre MA,López-Curbelo A,de Andrés M,Garcia-Courtay C,Cuadrado MJ

    更新日期:1998-01-01 00:00:00

  • Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.

    abstract::We retrospectively analysed the prevalence and clinical features associated to anti-Ku antibodies in patients affected by different autoimmune diseases. Anti-Ku antibodies are detected in 147 sera out of 7239 anti-ENA positive sera (2%). They are found in 2% of patients with systemic sclerosis (SSc) (8 out of 379), 1....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089442

    authors: Cavazzana I,Ceribelli A,Quinzanini M,Scarsi M,Airò P,Cattaneo R,Franceschini F

    更新日期:2008-08-01 00:00:00

  • Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.

    abstract::Objective Several studies have evaluated the prevalence of rheumatoid factor (RF) and anti-citrullinated proteins antibodies (ACPA) in systemic lupus erythematosus (SLE) patients but no data are available on the anti-carbamylated proteins (anti-CarP), a new biomarker for rheumatoid arthritis (RA). We evaluated the ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317713141

    authors: Massaro L,Ceccarelli F,Colasanti T,Pendolino M,Perricone C,Cipriano E,Natalucci F,Capalbo G,Lucchetti R,Pecani A,Vomero M,Mancini R,Spinelli FR,Alessandri C,Valesini G,Conti F

    更新日期:2018-01-01 00:00:00

  • Genetic selection pressure in TLR9 gene may enforce risk for SLE in Indian Tamils.

    abstract::Objectives Lupus is a classical systemic autoimmune disease with genetics as one of the well known causative factors for the disease pathogenesis. Toll-like receptors are the major pattern recognition receptors associated with innate immunity and also act as an interface with the adaptive immunity. Genetic polymorphis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316659151

    authors: Yusuf JH,Kaliyaperumal D,Jayaraman M,Ramanathan G,Devaraju P

    更新日期:2017-03-01 00:00:00

  • Autoantibody responses to cardiolipin and DNA in infancy: association with lymphocytic panniculitis.

    abstract::We report an infant with anticardiolipin (aCL) antibodies who presented with erythematous nodular skin lesions and elevated liver enzyme levels. The cutaneous manifestation was histologically lymphocytic lobular panniculitis with vasculitic and hemorrhagic changes. The infant also had low levels of anti-double strande...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300678828721

    authors: Miyagawa S,Uchida Y,Taira K,Higuchi M,Hashimoto K,Yoshioka A,Shirai T

    更新日期:2000-01-01 00:00:00

  • Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.

    abstract::To evaluate the efficacy of hydroxychloroquine (HCQ) and quinacrine (Qn) association, at two different dosages, in treatment of lupus skin lesions not responding to HCQ alone. Thirty-four patients, affected by cutaneous and systemic lupus erythematosus, were retrospectively analysed. They were treated by HCQ (5 mg/Kg/...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308101714

    authors: Cavazzana I,Sala R,Bazzani C,Ceribelli A,Zane C,Cattaneo R,Tincani A,Calzavara-Pinton PG,Franceschini F

    更新日期:2009-07-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Feto-maternal immune interaction at the placental level.

    abstract::A special interaction is established during pregnancy between the maternal immune system and fetal cells to allow the survival and the normal growth of the fetus. Fetal cells expressing paternal alloantigens are not recognized as foreign by the mother because of an efficient anatomic barrier and a local immunosuppress...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203304lu2010oa

    authors: Bulla R,Fischetti F,Bossi F,Tedesco F

    更新日期:2004-01-01 00:00:00

  • Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.

    abstract::We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker f...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400414

    authors: Stojanov L,Satoh M,Dooley MA,Kuwana M,Jennette JC,Reeves WH

    更新日期:1995-08-01 00:00:00

  • Antiphospholipid syndrome and the idiotypic network.

    abstract::To study whether monoclonal anticardiolipin antibodies (aCL), derived from patients with antiphospholipid syndrome (APS), have similar pathogenic potential, we have employed an experimental model of antiphospholipid syndrome. Monoclonal aCL were produced by the combined method of EBV transformation and somatic cell hy...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400307

    authors: Bakimer R,Blank M,Kosashvilli D,Ichikawa K,Khamashta MA,Hughes GR,Koike T,Shoenfeld Y

    更新日期:1995-06-01 00:00:00

  • Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus.

    abstract:OBJECTIVES:Impaired function of polymorphonuclear cells (PMNs) in systemic lupus erythematosus (SLE) leads to severe gram-positive and gram-negative bacterial infection, and to major morbidity and mortality. Few studies have focused on the association of impaired function of PMNs and SLE patients' susceptibility to inf...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312474704

    authors: Wu SA,Yeh KW,Lee WI,Yao TC,Kuo ML,Huang B,Huang JL

    更新日期:2013-03-01 00:00:00

  • The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.

    abstract::Objective The lupus impact tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of systemic lupus erythematosus or its treatment on patients' daily lives. Herein, we describe the responsiveness of the LIT and LupusQoL to changes in disease activity, using the systemic lupus erythematosus resp...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203316667494

    authors: Devilliers H,Bonithon-Kopp C,Jolly M

    更新日期:2017-04-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.

    abstract::Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847443

    authors: Fernández-Nebro A,Palacios-Muñoz R,Gordillo J,Abarca-Costalago M,De Haro-Liger M,Rodríguez-Andreu J,González-Santos P

    更新日期:1999-01-01 00:00:00

  • Unmodified and phosphorylated prolactin and gamma delta T cell development and function.

    abstract::This manuscript discusses our studies to date concerning the effects of unmodified prolactin (PRL) and phosphorylated PRL on immune function. Most of the discussion refers to effects of changing the ratio of these two forms in maternal PRL on gamma delta T cell development in rat pups in utero, but limited experiments...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301717164976

    authors: Walker AM

    更新日期:2001-01-01 00:00:00